This protocol describes the customized antibody-based fluorescence labeling and injection into early Drosophila embryos to enable live imaging of low-abundance proteins or post-translational modifications that are challenging to detect using traditional GFP/mCherry-tag approaches.
Visualization of proteins in living cells using GFP (Green Fluorescent Protein) and other fluorescent tags has greatly improved understanding of protein localization, dynamics, and function. Compared to immunofluorescence, live imaging more accurately reflects protein localization without potential artifacts arising from tissue fixation. Importantly, live imaging enables quantitative and temporal characterization of protein levels and localization, crucial for understanding dynamic biological processes such as cell movement or division. However, a major limitation of fluorescent tagging approaches is the need for sufficiently high protein expression levels to achieve successful visualization. Consequently, many endogenously tagged fluorescent proteins with relatively low expression levels cannot be detected. On the other hand, ectopic expression using viral promoters can sometimes lead to protein mislocalization or functional alterations in physiological contexts. To address these limitations, an approach is presented that utilizes highly sensitive antibody-mediated protein detection in living embryos, essentially performing immunofluorescence without the need for tissue fixation. As proof of principle, endogenously GFP-tagged Notch receptor that is barely detectable in living embryos can be successfully visualized after antibody injection. Furthermore, this approach was adapted to visualize post-translational modifications (PTMs) in living embryos, allowing the detection of temporal changes in tyrosine phosphorylation patterns during early embryogenesis and revealing a novel subpopulation of phosphotyrosine (p-Tyr) underneath apical membranes. This approach can be modified to accommodate other protein-specific, tag-specific, or PTM-specific antibodies and should be compatible with other injection-amenable model organisms or cell lines. This protocol opens new possibilities for live imaging of low-abundance proteins or PTMs that were previously challenging to detect using traditional fluorescent tagging methods.
Immunofluorescence is a cornerstone technique of modern cell biology originally developed by Albert Coons, which enables the detection of molecules at their native cellular compartments and characterization of the molecular compositions of subcellular organelles or machineries1. Coupled with genetic manipulations, immunofluorescence helps establish the now well-accepted concept that protein localization is essential for its function2. Aside from specific primary antibodies and bright fluorescent dyes, the success of this technique relies on a preliminary process named fixation and permeabilization, which preserves cellular morphologies, immobilizes antigens, and increases the accessibility of antibodies into intracellular compartments. Inevitably, the fixation and permeabilization process would kill cells and terminate all biological processes3. Therefore, immunofluorescence only provides snapshots of the life journey of proteins. However, many biological processes such as cell migration and divisions are dynamic in nature, requiring investigation of protein behaviors in a spatial-temporally resolved manner4,5.
To examine protein dynamics in living organisms, live imaging methods based on genetically encoded fluorescent proteins such as green fluorescent protein (GFP)6 and high-speed confocal microscopes have been developed. Briefly, the protein of interest can be genetically manipulated to be fused with GFP7, and then ectopically expressed from viral or yeast promoters such as cytomegalovirus (CMV)8 or upstream activation sequence (UAS)9. Because GFP is autofluorescent in nature, no fluorophore-coupled antibodies are required to reveal the localization of target proteins, which bypasses the necessity of preliminary processes of fixation or permeabilization. Over the last two decades, fluorescent tags spanning the whole spectrum of wavelength have been developed10, enabling multi-color live imaging of several target proteins at the same time. However, compared to chemically engineered fluorescent dyes such as AlexaFluor or ATTO, the autofluorescence of these genetically encoded fluorescent proteins is relatively weak and unstable when expressed from endogenous promoters, especially during live imaging over longer time scales10. While this shortfall can be mitigated by over-expressing fluorescently tagged target proteins, many with enzymatic activities such as kinases and phosphatases severely disrupt normal biological processes if not expressed at physiological levels.
This protocol presents a method that enables photostable antibody-based target illumination in a live image setup, essentially allowing immunofluorescence without the process of fixation or permeabilization (Figure 1). Through a simple NHS-based primary amine reaction11, one can conjugate fluorescent dyes such as AlexaFluor 488 or 594 with essentially any primary antibody or GFP/HA/Myc nanobody12. Taking advantage of a developmental feature that all Drosophila embryonic cells share a common cytoplasm during the syncytium stage13, one can achieve antigen binding and illumination across entire embryos after the injection of dye-conjugated antibodies. With expanding libraries of endogenously tagged proteins available in Drosophila and other model systems14, this method can potentially broaden applications of these libraries by revealing dynamics of low-abundance fluorescently tagged proteins and other non-fluorescently tagged (HA/Myc-tagged) proteins in living tissues.
The experiments were conducted in accordance with the guidelines and approval of the School of Life Sciences, SUSTech University. The organism used is Drosophila melanogaster, and the genotypes are Notch-Knockin-GFP (Chromosome X) and Sqh-sqh-GFP (Chromosome II), generously provided by the labs of Dr. Francois Schweisguth (Institute Pasteur) and Dr. Jennifer Zallen (Sloan Kettering Institute), respectively. While this protocol mainly focuses on aspects of antibody labeling and live imaging, please refer to published reports for more detailed descriptions of Drosophila embryo collection and injection15,16.
1. Fluorescent labeling of antibodies
2. Preparation of Drosophila embryos
3. Embryo alignment and desiccation
4. Antibody Injection and imaging
To demonstrate the advantages of the antibody injection method over fluorescent-tag-based live imaging or immunofluorescence, two case studies are provided that characterize the dynamic localization of a low-abundance transmembrane receptor, Notch, and a type of post-translational modification called tyrosine phosphorylation in living embryos.
Notch signaling activity plays a major role in cell fate determination during embryogenesis and adult organ homeostasis18,19. Upon activation by its ligands Delta/Jagged20, the intracellular domain of the transmembrane receptor Notch is cleaved and released into the nucleus21, initiating downstream transcriptional programs to drive cell fate changes22. The static localization of the Notch receptor has been well-characterized by immunofluorescence in formaldehyde-fixed tissues. However, the dynamic localization of Notch during ligand binding or the intracellular cleavage process remains largely unknown23, due to the lack of a method for live imaging this relatively low-abundance protein in a high-speed manner. Here, we injected AlexaFluor-conjugated GFP nanobody into embryos expressing GFP-tagged Notch from the endogenous locus20. Without injection, Notch-GFP is barely detectable under standard live imaging conditions, and the fluorescent signal quickly bleaches during time-lapse imaging. After injection, the signal-to-noise ratio of the Notch receptor significantly improves, comparable to the signal quality of immunofluorescence (Figure 3A). Moreover, antibody injection allows for the temporal characterization of Notch localization at 45 s intervals, without an apparent loss of signal intensity over a 5 min imaging window (Figure 3B).
Tyrosine phosphorylation is a major type of post-translational protein modification that mediates signal transduction in many biological pathways24. Highly specific monoclonal antibodies (such as PY20 and 4G10) against phosphotyrosine (p-Tyr) have been developed to characterize the localization and levels of overall tyrosine phosphorylation using immunofluorescence and western blots25. While no fluorescent tags can track phosphorylation changes, tissues or cells need to be fixed and stained or lysed and blotted at different time points to provide snapshots of the phosphorylation status over time, to study the kinetics of tyrosine phosphorylation upon signal activation26 (e.g., growth factor treatment). The time interval of this approach is at least a few minutes long and inherently inaccurate due to the variable time required for procedures such as fixation or cell lysis.
Here, evidence is presented that the antibody injection method enables the direct visualization of the phosphorylation status in living embryos, tracking the localization and intensity changes of tyrosine phosphorylation at regular, seconds-level time intervals. AlexaFluor-conjugated PY20 antibody was injected into embryos expressing GFP-tagged myosin light chain and performed dual-color live imaging at 45 s intervals. As it was previously shown, tyrosine phosphorylation is highly enriched at tricellular junctions27, a pattern that is also recapitulated by immunofluorescence (Figure 4A). Interestingly, live imaging also revealed a novel, second population of p-Tyr signal underneath the center of the apical membrane, which is not observed using immunofluorescence (Figure 4B). Through dual-color imaging, it was found that this population of p-Tyr signal is in close vicinity to medial myosin (Figure 4B, close-ups), a subpopulation of myosin28 that is similarly only pronounced in live imaging conditions but barely detectable using immunofluorescence. In addition, the medial population of p-Tyr exhibits similar pulsatile coalescence and dissipation patterns (Figure 4C), as previously shown for medial myosin28. The identity and function of a medial subpopulation of p-Tyr are still unknown. Together, these results demonstrate that the antibody injection method could greatly complement traditional approaches to characterize behaviors of low-abundance proteins and reveal novel localization patterns that might have been disrupted during the process of immunofluorescence.
Figure 1: Antibody injection workflow. Schematic workflow illustrating the steps involved in the antibody injection method. The entire process, from embryo collection to antibody injection, typically takes around 4-5 h to complete. After antibody injection, embryos can be incubated in a humidity chamber to the desired stage of development before live imaging. AEL, after egg laying; RT, room temperature; Ab, antibody. Please click here to view a larger version of this figure.
Figure 2: Embryo alignment and injection. (A) Overview of the items required before injection, including a coverslip, glass slide, desiccation box, paintbrush, tweezers, cell strainer, humidity chamber, and agarose gel. (B) Aligned embryos attached to heptane glue in the center of the coverslip and placed on top of desiccation beads. (C) Alignment of the embryos' anterior-posterior axis in parallel with the edge of the agarose gel. (D) Overview of the injection setup. (E) Comparison of embryo morphology before and after the desiccation process, with a focus on the wrinkle of the vitelline membrane after desiccation. (F) Size of the injection bubble after a single press of the picopump. (G) Comparison of embryo morphology before and after antibody injection, highlighting the disappearance of membrane wrinkles post-injection. (E–G) were captured under a 10x magnification objective lens using bright-field microscopy. Please click here to view a larger version of this figure.
Figure 3: Live imaging of Notch receptor in early embryos. (A) Localization of endogenously GFP-tagged Notch receptor through immunofluorescence (left), direct live imaging based on GFP autofluorescence (middle), and AlexaFluor 594-conjugated GFP nanobody injection (right). (B) Dynamic localization of Notch-GFP imaged at 45 s intervals after antibody injection. All images were acquired with the anterior of the embryos to the left and the ventral side facing down. Scale bars = 10 µm. Please click here to view a larger version of this figure.
Figure 4: Live imaging of embryonic phosphotyrosine patterns. (A) Localization of phosphorylated tyrosine (p-Tyr) in fixed embryos through immunofluorescence. (B) Localization of p-Tyr (magenta) in live embryos expressing GFP-tagged myosin light chain (green). The white dashed box indicates close-up views of the medial population of phosphotyrosine and myosin under the apical membrane. Scale bars = 10 µm. (C) Localization of p-Tyr and GFP-myosin imaged every 45 s in live embryos. White arrows indicate the medial population of p-Tyr and myosin. All images were captured with the anterior of the embryos to the left and the ventral side facing down. Scale bars = 10 µm. Please click here to view a larger version of this figure.
This presented procedure outlines the specialized method of fluorescence labeling with custom antibodies and subsequent injection into early-stage Drosophila embryos. This technique facilitates real-time visualization of proteins or post-translational modifications that exist in low quantities and are typically difficult to observe through conventional GFP/mCherry tagging methods.
Caution should be exercised when extending this method to make quantitative comparisons between wild-type and mutant embryos. While the concentration of primary and secondary antibodies can be kept the same between control and experimental groups in immunofluorescence, the amount of antibody injected and the labeling efficiency could vary between embryos. Therefore, quantitative analysis should be limited to tracking fluorescent intensity changes over time or conducting correlation analysis with signals of other channels in the same embryo when performing multi-color live imaging. For example, colocalization and correlation analysis can be performed using p-Tyr and myosin intensities27, whereas p-Tyr intensities cannot be directly compared between wild-type and gene-X knockdown embryos using the antibody injection method.
Similar to other fluorescent-tag-based approaches to examine protein dynamics, antibody binding could potentially alter the activity, trafficking, or localization of target proteins. Therefore, monoclonal antibodies or nanobodies are preferred over polyclonal antibodies for injection. Because the epitopes of monoclonal antibodies or nanobodies are well defined, whether blocking these epitopes with antibodies alters protein activity could be modeled based on alpha-fold structures12,25. On the other hand, epitopes of polyclonal antibodies are not precisely delineated, and their binding could potentially alter protein localization or activity if catalytic pockets or signal peptides of target proteins are blocked. Second, antibodies can recognize non-specific epitopes other than target proteins, especially considering that there are no "washout" steps here, as in immunofluorescence, to remove lower-affinity non-specific bindings. Therefore, it is important to have control groups, such as injecting antibodies into cells lacking the epitope, to verify whether the signal observed truly reflects the target proteins or other non-specific epitopes.
The injection of antibodies is no different from injecting siRNA or CRISPR gRNAs in terms of experimental setup. Therefore, most cellular systems that are amenable to injections should be compatible with the antibody injection method. In Drosophila embryos, Alexa Fluor-conjugated antibodies are stable during development, and fluorescent signals remain detectable after hours of embryogenesis. For other systems such as Xenopus or Zebrafish embryos, the concentration and injection volume of antibodies should be empirically tested through serial dilutions to achieve ideal labeling efficiency. In addition, alternative fluorescent dyes such as ATTO10 could potentially offer a better signal-to-noise ratio and water solubility.
The authors have nothing to disclose.
We would like to thank Dr. Jennifer A. Zallen for providing the Sqh-GFP Drosophila line and support for the initial development of this technique, and Dr. Francois Schweisguth for providing the Notch-GFP Drosophila line. This work was supported by funding from the National Natural Science Foundation of China (32270809) to H.H.Yu, generous financial and staff support from the School of Life Sciences, SUSTech, and funding to Y. Yan from Shenzhen Science and Technology Innovation Commission/JCYJ20200109140201722.
Agarose | Sangon Biotech | A620014 | |
Alexa Fluor 594 Antibody Labeling Kit | Invitrogen | A20185 | Purification column from step 1.6 is included in this kit |
Biological Microscope | SOPTOP | EX20 | Eyepiece lens: PL 10X/20. Objective lens: 10x/0.25 |
Bleach | Clorox® | ||
Borosilicate Glass Capillaries | World Precision Instruments | TW100F-4 | |
Centrifuge | Eppendorf | 5245 | |
Cell Strainer | FALCON | 352350 | |
Desiccation chamber | LOCK&LOCK | HSM8200 | 320ml |
Dissecting Microscope | Mshot | MZ62 | Eyepiece lens: WF10X/22mm. |
Double-sided Tape | Scotch | 665 | |
Fine Super Tweezer | VETUS | ST-14 | |
Fisherbrand™ Cover Glasses: Rectangles | Fisherbrand | 12-545F | |
Fisherbrand™ Superfrost™ Plus Microscope Slides | Fisherbrand | 12-550-15 | |
Forcep | VETUS | 33A-SA | |
Halocarbon oil 27 | Sigma-Aldrich | H8773-100ML | |
Halocarbon oil 700 | Sigma-Aldrich | H8898-100ML | |
Heptane | Sigma-Aldrich | H2198-1L | Heptane glue is made of double-sided tape immersed in heptane |
Dehydration reagent | TOKAI | 1-7315-01 | Fill to 90% volume of the dessication chamber |
Manual Micromanipulator | World Precision Instruments | M3301R | |
Micropipette puller | World Precision Instruments | PUL-1000 | Procedure: step 1, Heat: 290, Force:300, Distance:1.00, Delay:50. Step 2, Heat: 290, Force:300, Distance:2.21, Delay:50 |
Pneumatic picopump | World Precision Instruments | PV 830 | Eject: 20 psi; Range: 100ms; Duration: timed |
PY20 | Santa Cruz | SC-508 | |
Square petri dishes | Biosharp | BS-100-SD | |
GFP nanobody | Chromotek | gt |